DONATE
Our mission is to fuel discoveries to prevent, treat and cure cancer and make them available for beneficiaries

IMMUNE ONCOLOGY RESEARCH INSTITUTE

OUR INITIATIVES

LATEST UPDATES

IMMONC at the ASCO 2024 Annual Meeting

VIEW MORE

Update on the “Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone. Can This Modality Improve the Antiemetic Effect” trial

VIEW MORE

Astghik Voskanyan presented recent developments of the BPDCN International Registry at the 29th Congress of EHA

VIEW MORE

OncoDaily Leukemia Conference

VIEW MORE

OncoThon 2024

VIEW MORE
OUR TEAM VIEW ALL MEMBERS